Cancer

(Best Syndication News) There have been many cancer-fighting advances over the past few years. The newest approach is the “whole body” system. It combines surgery, chemotherapy and radiation with less than “traditional” therapies that were once dismissed by the medical industry.

These non-traditional therapies include acupuncture, pain and stress management along with nutrition. Some patients may find relief with yoga.

Doctor Mehmet Oz brought three cancer experts onto his show Friday. Doctor Steven Standiford, MD, surgeon at the Cancer Treatment Centers of America, Doctor Deborah Axelrod, MD, a director at the NYU Cancer Institute, and nutritionist Rachel Beller, RD spoke to Dr Oz Friday.

PD - National Cancer Institute

(Best Syndication News) - A recent study from the University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine found that getting an average of less than six hours of sleep each night increased a persons risk for developing colon cancer. The study results were published in the February 15, 2011 issue of the journal Cancer.

The lead researcher, Li Li, MD, PhD who is a family medicine physician in the Department of Family Medicine at UH Case Medical Center and Associate Professor of Family Medicine, Epidemiology and Biostatistics at Case Western Reserve University School of Medicine, said that they believe that this is the first study to find a colon cancer risk associated with the amount of sleep a person has on average each night.

The study results found a 50 percent increased risk for developing a colorectal adenomas with a person that averaged less than six hours of sleep each nigh to compared with a person that slept at least seven hours each night. While the adenoma is not cancer, it could develop into colon cancer tumors if they are not treated and become malignant.

Best Syndication News

(Best Syndication News) - The US Food and Drug Administration (FDA) announced a potential associated increased risk of saline and silicone gel-filled breast implants and a rare anaplastic large cell lymphoma cancer. The increased risk is small said the FDA, but at the same time is significant.

The FDA is asking health care professionals to report any women that have been diagnosed with anaplastic large cell lymphoma cancer so they can further evaluate this potential risk for ALCL cancer and breast implants. Because of the potential cancer risk, the FDA will be working with breast implant manufacturing companies to include notices of the cancer risk.

The National Cancer Institute said that ALCL is diagnosed in 1 out of 500,000 women each year. ALCL found in breast tissue is diagnosed 3 out of every 100 million in women without breast implants every year.

photo courtesy of Bill Branson (Photographer) National Cancer Institute (NCI) PD

(Best Syndication News) - Surving colon cancer might be improved with consistent exercise said a new study conducted at the Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis.

The researchers worked with data collected during the American Cancer Society Prevention Study II (CPS II) to determine if exercise would reduce the risk for dying from colon cancer. The CPS II study collected data from 150,000 men and women. In this study, the researchers looked specifically at exercise habits and colon cancer survival. The prognosis for those who exercised for at least 10 years had the lowest chance of dying from colon cancer.

The researchers pointed out that the people who were sedentary in adulthood died from colon cancer more often than those who exercised and remained active over the years. Lead author Kathleen Y. Wolin, ScD suggests that “It's never too late to start exercising.”

Photo courtesy CDC/ James Gathany PD

(Best Syndication News) - According to recent study, the exact opposite an “un-growth” hormone showed anti-aging potential. The compound is called MZ-5-156 and is a growth hormone-releasing hormone (GHRH) antagonist. The study results were published in the online December 6th edition of the National Academy of Sciences.

John E. Morley, M.D., study co-investigator and director of the divisions of geriatric medicine and endocrinology at Saint Louis University School of Medicine said that older people taking growth hormone supplements to reverse aging may actually “be hazardous”.

The researchers studied a SAMP8 mouse model for aging and they discovered that the MZ-5-156 had showed a beneficial outcome for oxidative stress in the brain. This helped the mice have better cognition and the telomerase activity was improved. The mice also had an increased life span while at the same time decreasing the amount of tumors. The MZ-5-156 also has been found in other research to repress prostate, breast, brain and lung cancer in humans. In addition there has been research that have measured improvement on short-term memory and improved learning. In this study, the MZ-5-156 created an antioxidant action that reduced oxidative stress and reversed cognitive damage in the mice as they aged.